Add like
Add dislike
Add to saved papers

Evaluation of Early Results Video-Assisted Thoracoscopic Surgery with Multi-Joint Wristed Instruments in Lung Cancer Surgery.

Background: Our objective in this study is to compare the early outcomes of patients who underwent technical resection of non-small cell lung cancer (NSCLC) with video-assisted thoracoscopic surgery (VATS) with multi-joint wristed instruments, also known as surgeon-powered robotic surgery (SpRS) and conventional VATS. Methods: One hundred twenty-two thoracoscopic lung resections were performed in our hospital for NSCLC between March 2021 and March 2022. Of these resections, 95 were performed with VATS, while 27 patients underwent the SpRS technique. Results: Lobectomy was performed in 112 patients (91.8%), and segmentectomy was performed in 10 patients (8.2%). The median duration of hospitalization was 5 days in patients who underwent VATS, while the median duration of hospitalization was 4 days in patients who underwent the SpRS technique. No significant difference was found between the groups when demographic characteristics were compared with surgical techniques. The median drainage was 125 mL in the SpRS technique, while 150 mL of drainage occurred in patients who underwent resection by VATS (0.165). While an average of 12 lymph nodes was dissected in the VATS group, an average of 14 lymph nodes was dissected in the SpRS group (0.602). Complications occurred in 17 patients (13.9%). Complications were observed at a rate of 16.8% in the VATS group, while complications were observed at a rate of 3.7% in the SpRS group ( P  = .116). Conclusion: As a result, our study shows that it is an effective and reliable method with early results similar to thoracoscopic surgery. Registration Number: 2022-194.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app